Literature DB >> 51882

Antigenic determinants of the 70,000 molecular weight glycoprotein of woolly monkey type C RNA virus.

S Hino, J R Stephenson, S A Aaronson.   

Abstract

The 70,000 molecular weight glycoprotein (gp70) of a type-C RNA virus originally isolated from a woolly monkey has been partially purified and immunologically characterized. Evidence that this viral protein is viral coded was derived from studies showing its antigenic properties to be unaltered by virus passage in cells of different species. A broadly reactive competition immunoassay was developed utilizing antiserum prepared against feline leukemia virus to precipitate 125I-labeled woolly monkey virus gp70. Gibbon and woolly viruses, as well as feline and several mouse type-C viruses, all reacted with equal efficiency in this assay. In contrast, an endogenous virus of the baboon failed to cross-react, suggesting that viruses of this latter group are less immunologically related to the others. In a homologous competition immunoassay for the woolly viral glycoprotein, the woolly virus was readily distingusihed from otherwise colsely related viruses of gibbon apes. These findings demonstrate the pronounced type-specific antigenic dterminants possessed by this viral protein. The antigenic determinants of gp70 responsible for neutralization have also been investigated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51882

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Endogenous RD-114 virus of cats: absence of antibodies to RD-114 envelope antigens in cats naturally exposed to feline leukemia virus.

Authors:  M P Mandel; J R Stephenson; W D Hardy; M Essex
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

2.  Structural analysis of the genomes of gibbon ape and woolly monkey leukosis viruses.

Authors:  B G Sahagan; W A Haseltine
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

3.  Spontaneous mutations affecting the host range of the B77 strain of avian sarcoma virus involve type-specific changes in the virion envelope antigen.

Authors:  D A Zarling; A G Mosser; H M Temin
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

4.  Biochemical and immunological characterization of the major envelope glycoprotein of bovine leukemia virus.

Authors:  S G Devare; J R Stephenson
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

5.  Biochemical and immunological characterization of the major envelope glycoprotein gp69/71 and degradation fragments from Rauscher leukemia virus.

Authors:  M J Krantz; M Strand; J T August
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

6.  Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera.

Authors:  S Hino; J R Stephenson; S A Aaronson
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

7.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis.

Authors:  S G Devare; E P Reddy; J D Law; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Endogenous RD-114 virus genome expression in malignant tissues of domestic cats.

Authors:  H L Niman; M B Gardner; J R Stephenson; P Roy-Burman
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

9.  Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.

Authors:  J R Stephenson; M Essex; S Hino; W D Hardy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  DNA sequence relationship of the baboon endogenous virus genome to the genomes of other type C and type D retroviruses.

Authors:  M Cohen; N Rice; R Stephens; C O'Connell
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.